EntryPoint Capital »

Perspective Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $101k 30k 3.41

More positions owned by EntryPoint Capital

Standardaero (SARO)
Howmet Aerospace (HWM)
Benchmark Electronics (BHE)
Capital One Financial (COF)
Hayward Hldgs (HAYW)
Huntington Bancshares Incorporated (HBAN)
Bank of America Corporation (BAC)
RBC Bearings Incorporated (RBC)
Gilead Sciences (GILD)
Avient Corp (AVNT)
Donaldson Company (DCI)
Universal Display Corporation (OLED)
Helios Technologies (HLIO)
HEICO Corporation (HEI)
American Homes 4 Rent Cl A (AMH)

View all positions for EntryPoint Capital

Top funds holding Perspective Therapeutics

BlackRock
TCG Crossover Management
Commodore Capital
Avidity Partners Management
Millennium Management
Vanguard Capital Management
Affinity Asset Advisors
Citadel Advisors
Spruce Street Capital
Balyasny Asset Management
State Street Corporation
Morgan Stanley
Geode Capital Management
Nantahala Capital Management
Goldman Sachs Group

View all funds holding Perspective Therapeutics